Arrowhead Pharmaceuticals, Inc.: Form 10-Q for the period ended Dec 31, 2024
Filed with the SEC on Feb 10, 2025 and accepted by EDGAR at Feb 10, 2025, 16:02 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-10-01 to 2024-12-31 | $2.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Operating income | 3 months2024-10-01 to 2024-12-31 | −$161.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-10-01 to 2024-12-31 | $21.6m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2024-10-01 to 2024-12-31 | $103.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-10-01 to 2024-12-31 | −$173.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-10-01 to 2024-12-31 | −$1.39 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-10-01 to 2024-12-31 | −$1.39 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-10-01 to 2024-12-31 | 124,848,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2024-10-01 to 2024-12-31 | −$146.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2024-10-01 to 2024-12-31 | $7.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Current assets | At period end2024-12-31 | $570.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-12-31 | $1.01bn | us-gaap:Assets |
| Current liabilities | At period end2024-12-31 | $93.8m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2024-12-31 | $52.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-25-004634. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.